Taolei Sun

Dr. Taolei Sun

School of Chemistry, Chemical Engineering and Life Sciences, Wuhan University of Technology, China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2021 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
BCBaisong Chang
Baisong Chang
DLDaifeng Li
Daifeng Li
YRYing Ren
Ying Ren
CQChunrong Qu
Chunrong Qu
XSXiaojing Shi
Xiaojing Shi
ZCZhen Cheng
Zhen Cheng

20 September 2022 in Cell Biology and Toxicology
Verified
Journal Article
Closed access
PDF file
SLShijie Li
Shijie Li
ZLZhixin Lei
Zhixin Lei
TSTaolei Sun
Taolei Sun

17 February 2017 in Nanoscale
Verified
Journal Article
Closed access
PDF file
GGGuanbin Gao
Guanbin Gao
MZMingxi Zhang
Mingxi Zhang
DGDejun Gong
Dejun Gong
RCRui Chen
Rui Chen
XHXuejiao Hu
Xuejiao Hu
TSTaolei Sun
Taolei Sun
A significant pathological signature of Alzheimer's disease (AD) is the deposition of amyloid-β (Aβ) plaques in the brain and the synaptic dysfunction and neurodegeneration associated with it. Compounds or drugs that inhibit Aβ fibrillation are thus desirable to develop novel therapeutic strategies against AD. Conventional strategies usually require an elaborate design of their molecular structures. Here we report the size-effect of gold nanoparticles (AuNPs) and nanoclusters (AuNCs) in the inhibition of protein amyloidosis. Using L-glutathione stabilized AuNPs with different sizes and AuNCs as examples, we show that large AuNPs accelerate Aβ fibrillation, whereas small AuNPs significantly suppress this process. More interestingly, AuNCs with smaller sizes can completely inhibit amyloidosis. Dynamic light scattering (DLS) experiments show that AuNCs can efficiently prevent Aβ peptides from aggregation to larger oligomers (e.g. micelles) and thus avoid nucleation to form fibrils. This is crucially important for developing novel AD therapies because oligomers are the main source of Aβ toxicity. This work presents a novel strategy to design anti-amyloidosis drugs, which also provides interesting insights to understand how biological nanostructures participate in vivo in Aβ fibrillation from a new perspective.

22 November 2023 in Chemical Reviews
Verified
Journal Article
Closed access
BCBaisong Chang
Baisong Chang
JCJie Chen
Jie Chen
JBJiasheng Bao
Jiasheng Bao
TSTaolei Sun
Taolei Sun
ZCZhen Cheng
Zhen Cheng

1 February 2019 in Biomaterials
Verified
Journal Article
Closed access
GGGuanbin Gao
Guanbin Gao
RCRui Chen
Rui Chen
MHMeng He
Meng He
JLJing Li
Jing Li
LWLiyun Wang
Liyun Wang
TSTaolei Sun
Taolei Sun

15 May 2013 in MRS Bulletin
Verified
Journal Article
Open access
PDF file
TWTak-Sing Wong
Tak-Sing Wong
TSTaolei Sun
Taolei Sun
LFLin Feng
Lin Feng
JAJoanna Aizenberg
Joanna Aizenberg
Various life forms in nature display a high level of adaptability to their environments through the use of sophisticated material interfaces. This is exemplified by numerous biological systems, such as the self-cleaning of lotus leaves, the water-walking abilities of water striders and spiders, the ultra-slipperiness of pitcher plants, the directional liquid adhesion of butterfly wings, and the water collection capabilities of beetles, spider webs, and cacti. The versatile interactions of these natural surfaces with fluids, or special wettability, are enabled by their unique micro/nanoscale surface structures and intrinsic material properties. Many of these biological designs and principles have inspired new classes of functional interfacial materials, which have remarkable potential to solve some of the engineering challenges for industrial and biomedical applications. In this article, we provide a snapshot of the state of the art of biologically inspired materials with special wettability, and discuss some promising future directions for the field.